文献速递肝病

非酒精性脂肪性肝病中的尿素循环失调

Urea cycle dysregulation in non-alcoholic fatty liver disease.
PubMed 文献 · J Hepatol · 2018-07-05

该研究在大鼠NASH模型和NAFLD患者中探究尿素循环酶的表达与功能变化及可逆性。结果显示NASH动物及患者OTC和CPS1表达与活性降低、氨浓度升高,伴启动子高甲基化;动物模型中该变化可逆,提示尿素循环失调与高氨血症相关。

要点

  • NASH动物模型中OTC和CPS1基因与蛋白表达及OTC活性可逆性降低,伴Otc启动子高甲基化。
  • NAFLD患者OTC酶浓度和活性降低、氨浓度升高,NASH患者进一步加重,OTC和CPS1启动子区高甲基化。
  • 原代大鼠肝细胞脂肪变性伴Otc启动子高甲基化、Otc和Cps1基因表达降低及上清氨浓度升高。

核心结论

  • NASH与尿素循环酶基因和蛋白表达及活性降低相关,可能通过尿素循环酶基因高甲基化和尿素合成受损导致高氨血症。
  • 作者称其研究首次描述NASH、尿素循环酶功能与高氨血症之间的联系,并提供新的治疗靶点。

研究设计与样本

  • 大鼠先喂食高脂高胆固醇饮食10个月诱导NASH,再换普通饲料恢复。
  • 人类研究获取20例脂肪变性患者和15例NASH患者的肝活检。
  • 分离并培养原代大鼠肝细胞,用游离脂肪酸处理。
  • 检测OTC和CPS1基因与蛋白表达、OTC活性及氨浓度,并评估大鼠、人类和脂肪变性肝细胞中OTC和CPS1启动子甲基化状态。

主要发现

  • NASH动物中OTC和CPS1基因与蛋白表达及OTC活性可逆性降低,并观察到Otc启动子基因高甲基化。
  • NAFLD患者OTC酶浓度和活性降低、氨浓度升高,NASH患者进一步加重;OTC和CPS1启动子区高甲基化。
  • 原代肝细胞中诱导脂肪变性伴Otc启动子高甲基化、Otc和Cps1基因表达降低及上清氨浓度升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: In non-alcoholic steatohepatitis (NASH), the function of urea cycle enzymes (UCEs) may be affected, resulting in hyperammonemia and the risk of disease progression. We aimed to determine whether the expression and function of UCEs are altered in an animal model of NASH and in patients with non-alcoholic fatty liver disease (NAFLD), and whether this process is reversible. METHODS: Rats were first fed a high-fat, high-cholesterol diet for 10 months to induce NASH, before being switched onto a normal chow diet to recover. In humans, we obtained liver biopsies from 20 patients with steatosis and 15 with NASH. Primary rat hepatocytes were isolated and cultured with free fatty acids. We measured the gene and protein expression of ornithine transcarbamylase (OTC) and carbamoylphosphate synthetase (CPS1), as well as OTC activity, and ammonia concentrations. Moreover, we assessed the promoter methylation status of OTC and CPS1 in rats, humans and steatotic hepatocytes. RESULTS: In NASH animals, gene and protein expression of OTC and CPS1, and the activity of OTC, were reversibly reduced. Hypermethylation of Otc promoter genes was also observed. Additionally, in patients with NAFLD, OTC enzyme concentration and activity were reduced and ammonia concentrations were increased, which was further exacerbated in those with NASH. Furthermore, OTC and CPS1 promoter regions were hypermethylated. In primary hepatocytes, induction of steatosis was associated with Otc promoter hypermethylation, a reduction in the gene expression of Otc and Cps1, and an increase in ammonia concentration in the supernatant. CONCLUSION: NASH is associated with a reduction in the gene and protein expression, and activity, of UCEs. This results in hyperammonemia, possibly through hypermethylation of UCE genes and impairment of urea synthesis. Our investigations are the first to describe a link between NASH, the function of UCEs, and hyperammonemia, providing a novel therapeutic target. LAY SUMMARY: In patients with fatty liver disease, the enzymes that convert nitrogen waste into urea may be affected, leading to the accumulation of ammonia, which is toxic. This accumulation of ammonia can lead to scar tissue development, increasing the risk of disease progression. In this study, we show that fat accumulation in the liver produces a reversible reduction in the function of the enzymes that are involved in detoxification of ammonia. These data provide potential new targets for the treatment of fatty liver disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. De Chiara F, Heebøll S, Marrone G, et al. Urea cycle dysregulation in non-alcoholic fatty liver disease. J Hepatol. 2018. PMID: 29981428. doi:10.1016/j.jhep.2018.06.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。